Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 1993Journal of Clinical Oncology

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

View Full Paper
Ask AI
Bookmark
Share

Authors

DGDavid R. GandaraUniversity of Southern CaliforniaJCJohn CrowleyTulane UniversityRLRobert B. LivingstonUniversity of Arkansas at Little Rock

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gandara et al. (1993) studied this question.

synapsesocial.com/papers/6a0fcbc192676d5461fd1791https://doi.org/10.1200/jco.1993.11.5.873
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.1991 · 737 citations
  2. 2High-Dose Cisplatin in Hypertonic Saline1984 · 334 citations